NO750542L - - Google Patents
Info
- Publication number
- NO750542L NO750542L NO750542A NO750542A NO750542L NO 750542 L NO750542 L NO 750542L NO 750542 A NO750542 A NO 750542A NO 750542 A NO750542 A NO 750542A NO 750542 L NO750542 L NO 750542L
- Authority
- NO
- Norway
- Prior art keywords
- cuvette
- aggregation
- disc
- approx
- plasma
- Prior art date
Links
- 230000002776 aggregation Effects 0.000 claims description 34
- 238000004220 aggregation Methods 0.000 claims description 34
- 230000002269 spontaneous effect Effects 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 7
- 238000005375 photometry Methods 0.000 claims description 3
- 210000001772 blood platelet Anatomy 0.000 description 26
- 210000002381 plasma Anatomy 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000031169 hemorrhagic disease Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000004623 platelet-rich plasma Anatomy 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000005496 tempering Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 229920001499 Heparinoid Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000035480 Ring chromosome 8 syndrome Diseases 0.000 description 1
- 208000000392 Thrombasthenia Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 239000003705 antithrombocytic agent Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 239000002554 heparinoid Substances 0.000 description 1
- 229940025770 heparinoids Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000009424 thromboembolic effect Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742408214 DE2408214C3 (de) | 1974-02-21 | Verfahren zum Messen der spontanen Aggregation der Blutplättchen in blutplättchenreichem Zitratplasma B. Braun Melsungen AG, 3508 Melsun- |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO750542L true NO750542L (da) | 1975-08-22 |
Family
ID=5907981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO750542A NO750542L (da) | 1974-02-21 | 1975-02-18 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4066360A (da) |
| JP (1) | JPS553661B2 (da) |
| BR (1) | BR7501042A (da) |
| CH (1) | CH576641A5 (da) |
| DK (1) | DK145126C (da) |
| FI (1) | FI58700C (da) |
| FR (1) | FR2262306B1 (da) |
| GB (1) | GB1499435A (da) |
| NO (1) | NO750542L (da) |
| SE (1) | SE405644B (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1601222A (en) * | 1977-02-24 | 1981-10-28 | Schmitt H J | Method and apparatus for measurement of the aggregation rate of red blood corpuscles suspended in blood |
| DE2802033C2 (de) * | 1978-01-18 | 1987-02-26 | Albrecht M. Prof. Dr.med. 6072 Dreieich Ehrly | Verfahren und Vorrichtung zur Messung der Aggregationsgeschwindigkeit von roten Blutkörperchen in Blut |
| US4591793A (en) * | 1984-06-14 | 1986-05-27 | Freilich Arthur H | Aggregometer electrode structures |
| EP0364583A4 (en) * | 1988-04-20 | 1991-08-28 | Vsesojuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskikh Nauk Sssr | Method and device for analyzing thrombocyte aggregation |
| US6043871A (en) * | 1997-03-03 | 2000-03-28 | Brigham Young University | System and method for measuring blood platelet function |
| US20070243632A1 (en) * | 2003-07-08 | 2007-10-18 | Coller Barry S | Methods for measuring platelet reactivity of patients that have received drug eluting stents |
| WO2005007868A2 (en) | 2003-07-08 | 2005-01-27 | Accumetrics, Inc. | Controlled platelet activation to monitor therapy of adp antagonists |
| US7595169B2 (en) * | 2005-04-27 | 2009-09-29 | Accumetrics, Inc. | Method for determining percent platelet aggregation |
| GB2432660A (en) | 2005-11-29 | 2007-05-30 | Bacterioscan Ltd | System for counting bacteria and determining their susceptibility to antibiotics |
| WO2008137673A1 (en) * | 2007-05-03 | 2008-11-13 | Accumetrics, Inc. | Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists |
| US8289514B2 (en) * | 2008-03-05 | 2012-10-16 | Aggredyne, Inc. | Systems for measuring properties of a physiological fluid suspension |
| US8772040B2 (en) * | 2012-08-31 | 2014-07-08 | Korea University Research And Business Foundation | Apparatus and method of platelet multi-function analysis, and micro stirring chip |
| WO2015084967A1 (en) | 2013-12-06 | 2015-06-11 | BacterioScan Inc. | Optical measurements of liquids having free surface |
| EP3077794A4 (en) | 2013-12-06 | 2017-12-13 | Bacterioscan Ltd. | Optical measurement cuvette having sample chambers |
| CN103743592B (zh) * | 2014-01-07 | 2016-01-20 | 山东天地缘酒业有限公司 | 一种成品酒检验用取样管的固定架 |
| US10233481B2 (en) | 2014-12-05 | 2019-03-19 | Bacterioscan Ltd | Multi-sample laser-scatter measurement instrument with incubation feature and systems for using the same |
| US20160161404A1 (en) | 2014-12-05 | 2016-06-09 | Bacterioscan Ltd | System Using Laser-Scatter Measurement Instrument For Organism Identification And Related Network |
| US10065184B2 (en) | 2014-12-30 | 2018-09-04 | Bacterioscan Ltd. | Pipette having integrated filtration assembly |
| CN107209115A (zh) | 2015-01-26 | 2017-09-26 | 百克特瑞欧扫描有限责任公司 | 具有转盘式流体样品装置的激光散射测量仪器 |
| US11099121B2 (en) | 2019-02-05 | 2021-08-24 | BacterioScan Inc. | Cuvette device for determining antibacterial susceptibility |
| WO2021105933A1 (en) * | 2019-11-27 | 2021-06-03 | Sangutech Enterprises Private Limited | A system and method for detecting platelet function using uv light and deep learning analyses of microscopic images |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3302452A (en) * | 1964-04-27 | 1967-02-07 | Cutler Hammer Inc | Coagulation detector and coagulability determination |
| BE755852A (fr) * | 1969-09-09 | 1971-03-08 | Hoffmann La Roche | Photometre |
| US3582218A (en) * | 1969-10-17 | 1971-06-01 | Atomic Energy Commission | Multistation photometric analyzer |
| DE2154066A1 (de) * | 1970-10-29 | 1972-05-04 | Clarke, Noel, Blackrock, Dublin | Verfahren und Vorrichtung zum Messen der Thrombozyten-Verklumpung in gesundem Blut |
| US3754866A (en) * | 1971-07-30 | 1973-08-28 | Sherwood Medical Ind Inc | Optical detecting system |
| US3876379A (en) * | 1973-07-25 | 1975-04-08 | Duk K Ghim | Blood agglutination testing apparatus |
-
1975
- 1975-02-18 NO NO750542A patent/NO750542L/no unknown
- 1975-02-18 FI FI750446A patent/FI58700C/fi not_active IP Right Cessation
- 1975-02-19 US US05/550,920 patent/US4066360A/en not_active Expired - Lifetime
- 1975-02-19 CH CH205275A patent/CH576641A5/xx not_active IP Right Cessation
- 1975-02-20 DK DK63975A patent/DK145126C/da active
- 1975-02-20 BR BR1042/75A patent/BR7501042A/pt unknown
- 1975-02-20 FR FR7505297A patent/FR2262306B1/fr not_active Expired
- 1975-02-21 SE SE7501971A patent/SE405644B/xx unknown
- 1975-02-21 GB GB7346/75A patent/GB1499435A/en not_active Expired
- 1975-02-21 JP JP2180975A patent/JPS553661B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US4066360A (en) | 1978-01-03 |
| DK145126C (da) | 1983-02-21 |
| FI750446A (da) | 1975-08-22 |
| DE2408214A1 (de) | 1975-09-04 |
| CH576641A5 (da) | 1976-06-15 |
| SE7501971L (da) | 1975-08-22 |
| SE405644B (sv) | 1978-12-18 |
| DK63975A (da) | 1975-10-20 |
| GB1499435A (en) | 1978-02-01 |
| FI58700B (fi) | 1980-11-28 |
| DK145126B (da) | 1982-09-06 |
| FI58700C (fi) | 1981-03-10 |
| DE2408214B2 (de) | 1976-04-29 |
| FR2262306B1 (da) | 1977-04-15 |
| JPS50127692A (da) | 1975-10-07 |
| BR7501042A (pt) | 1975-12-02 |
| FR2262306A1 (da) | 1975-09-19 |
| JPS553661B2 (da) | 1980-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO750542L (da) | ||
| US5091304A (en) | Whole blood activated partial thromboplastin time test and associated apparatus | |
| RU2079840C1 (ru) | Способ определения содержания фибриногена в антикоагулированной цельной крови | |
| JP6091649B2 (ja) | 遠心力のマイクロ流動ベースの血小板複合機能と薬物反応検査装置 | |
| JP3497862B2 (ja) | フィブリノーゲン測定を正確、迅速かつ簡単に行うための改良方法及び分析システム | |
| US5792660A (en) | Comparative determinants of viscosity in body fluids obtained with probes providing increased sensitivity | |
| KR20020042622A (ko) | 전혈내 응고 인자 활성을 측정하는 방법 | |
| US4201470A (en) | Method and apparatus for measurement and registration of the aggregation rate of particles suspended in a liquid | |
| JP6941061B2 (ja) | 血小板凝集能解析装置、血小板凝集能解析システム、血小板凝集能解析用プログラム及び血小板凝集能の解析方法 | |
| Lindahl et al. | Methods for evaluation of platelet function | |
| JP6239603B2 (ja) | 血液凝固の検査方法および装置 | |
| RU2061953C1 (ru) | Способ количественного определения общей коагуляционной активности тромбоцитов | |
| US5783447A (en) | Hypercoagulability comparative determinants obtained using detection systems with variable force-induced energy inputs | |
| JP6750443B2 (ja) | 血小板凝集能解析方法、血小板凝集能解析装置、血小板凝集能解析用プログラム及び血小板凝集能解析システム | |
| RU2419800C1 (ru) | Способ оценки риска повторных тромботических событий у больных острым коронарным синдромом | |
| US5318910A (en) | Standard whole blood composition for determining the potency of blood clotting inhibitory substances | |
| DE2408214C3 (de) | Verfahren zum Messen der spontanen Aggregation der Blutplättchen in blutplättchenreichem Zitratplasma B. Braun Melsungen AG, 3508 Melsun- | |
| Djabbarova et al. | A SUMMARY OF THE CLINICAL SIGNIFICANCE AND LABORATORY SPECIFICITY OF THE EVALUATION TEST DEFINITIONS | |
| Riddle | A method for evaluating the platelet surface response by using electron microscopy | |
| Lordkipanidzé et al. | Platelet function tests | |
| DE2707962C3 (de) | Verfahren und Vorrichtung zum Messen der Aggregationsgeschwindigkeit von roten Blutkörperchen in Blut | |
| Musumeci et al. | Platelet aggregation in native blood exposed to a shifting shear rate field | |
| Grassetto et al. | General aspects of viscoelastic tests | |
| RU2160448C2 (ru) | Способ определения фибринолитической активности мочи | |
| RU2129716C1 (ru) | Способ определения гипопротеинемии |